Cel-Sci Share Price

Cel-Sci Share Price

AMEX: CVM | Micro Cap | Healthcare
$1.40
-$0.43 (-23.5%) Last updated on 19 Nov, 2026 | 02:23 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Cel-Sci Stock Performance

Open
$1.61
Prev. Close
$1.83
Circuit Range
N/A
Day Range
$1.34 - $1.61
Year Range
$0.90 - $7.75
Volume
7,786
Average Traded
$1.43

Cel-Sci Share Price Today

As of 19 November 2026, Cel-Sci Corporation's share price is $1.40. The stock opened at $1.61, compared to its previous close of $1.83. During today's trading session, Cel-Sci Corporation's share price traded between $1.34 and $1.61, with an average price of $1.48. Over the past 52 weeks, the stock has recorded a high of $7.75 and a low of $0.90. In terms of performance, Cel-Sci Corporation's share price has declined by 9.09% over the last six months and is down 81.75% on a year-on-year basis.

Cel-Sci Share Price Chart

Line chart of the Cel-Sci price trend over the selected period. The price fell overall, ranging from 1.34 to 1.66, ending at 1.40.
$1.34$1.61
L
Show Current Price
H

Cel-Sci Stock Fundamentals & Key Indicators

Market Cap
$5.68M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.29
Revenue (TTM)
$0.00
Return On Equity (TTM)
-207.23%
Profit Margin
N/A
Debt to Equity
0.57
Quarterly Earnings Growth YoY
7.05%

Cel-Sci Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$6.10-$5.47-$5.47-$5.67
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A10.33%0.00%-3.66%

Cel-Sci Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$37.63-$32.37-$27.58-$25.41
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A13.98%14.80%7.87%

Cel-Sci Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets16.5620.9423.6125.09
Current Assets11.66.066.9225.44
Total Assets28.1626.9930.5350.52
Non Current Liabilities7.079.5111.7313.7
Current Liabilities5.134.625.594.66
Total Liabilities12.214.1217.3118.36
Shareholders' Equity15.9612.8713.2132.16

Cel-Sci Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-17.12-18.81-22.85-18.24
Investing-0.04-0.11-0.375.49
Financing23.3719.514.69-0.64

Corporate Actions

Split
Ex-date: 20 May 2025

About Cel-Sci

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Cel-Sci Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.44
$1.40
+0.36%
Oct 2026
$2.10
$1.39
-32.85%
Sep 2026
$1.58
$2.07
+27.78%
Aug 2026
$1.19
$1.62
+39.06%
Jul 2026
$1.05
$1.17
+10.95%
Jun 2026
$1.46
$1.05
-31.82%
May 2026
$2.83
$1.54
-51.11%
Apr 2026
$3.38
$3.15
+3.28%
Mar 2026
$3.77
$3.05
-27.21%
Feb 2026
$5.48
$4.19
-27.13%
Jan 2026
$5.33
$5.75
+6.48%
Dec 2025
$7.11
$5.40
-29.60%

Cel-Sci Share Price FAQs